top of page
The Professional Network for Healthcare Experts
Mankind Pharma agrees €48 million acquisition of 70% stake in Armed Cell Therapeutics to enter CAR-T oncology
Mankind Pharma has agreed to acquire a 70% stake in Belgium's Armed Cell Therapeutics for €48 million, marking its entry into next-generation CAR-T oncology therapies.
nuaxia
Oct 162 min read
Sudarshan Pharma approves acquisition of 9.5% stake in MedTherapy Biotechnology
Sudarshan Pharma has approved the acquisition of a 9.5% stake in US-based MedTherapy Biotechnology, expanding its exposure to oncology cell and gene therapy.
nuaxia
Sep 82 min read
ArsenalBio cuts 99 jobs as it pivots to in vivo CAR-T development
ArsenalBio is cutting 99 jobs as it restructures the company around a strategic shift towards in vivo CAR-T development.
nuaxia
Sep 21 min read
Bristol Myers Squibb ends $380 million Cellares CAR-T manufacturing partnership
BMS concluded that Cellares’ automated Cell Shuttle platform could not meet the specific requirements for commercial Breyanzi production, prompting Cellares to cut around 100 positions.
nuaxia
Aug 273 min read
bottom of page